Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Class I recall for Medtronic infusion pumps

This article was originally published in The Silver Sheet

Executive Summary

FDA has labeled as Class I a recall involving an intrathecal catheter connection problem in Medtronic's SynchroMed and IsoMed implantable infusion pump systems. Announced Sept. 26, the action covers four models of Indura One-Piece sutureless connector intrathecal catheters used with the pumps. More than 25,000 of the catheters have been sold in the United States, according to the company. The occlusions or disconnections can result in a "clinically significant or fatal drug overdose," drug withdrawal symptoms, lack of therapeutic effect or a return of underlying symptoms, the firm explains. In a June safety alert describing the problem before it was classified as a recall, Medtronic said that patients with misaligned or disconnected catheters will require corrective surgery. Previously, SynchroMed systems were the subject of an August 2007 recall due to pump gear shaft wear and a January 2008 recall citing the risk of inflammatory masses around catheter tips

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036281

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel